Italy Health Podcasts Italy Health RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

HMPRO: collecting specific QoL and symptom data for hematological malignancies
Quality of life and symptom data are essential for informing treatment plans as a clinician, as Esther Oliva, MD, of the Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Current techniques for treating iron-deficiency anemia
Iron-deficiency anemia is an extremely common form of anemia. Here, Maria Domenica Cappellini, MD, of the University of Milan-Foundation IRCCS Policlinico Hospital, Milan, Italy, speaks about differen... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Using MRD to inform allocation of stem cell transplants in ALL and AML
Fabio Guolo, MD, of the University of Genoa, Genoa, Italy, spoke to us at the 23rd Congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden, about how measurable residual ... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

MRD: common misconceptions and clinical considerations
Speaking from the 23rd Congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden, Fabio Guolo, MD, of the University of Genoa, Genoa, Italy, discusses misconceptions around... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

ERIC: current research and initiatives in CLL
Paolo Ghia, MD, of the Universit Vita-Salute San Raffaele, Milan, Italy, is the president of the European Research Initiative on CLL (ERIC), and he spoke to us at the 23rd Congress of European Hemato... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

MRD in AML clinical practice
Measurable residual disease (MRD) is rising in popularity as a prognostic indicator in a variety of blood cancer types. We spoke to Fabio Guolo, MD, of the University of Genoa, Genoa, Italy, at the 23... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Treatment benefits for elderly AML patients with azacitidine
Esther Oliva, MD, of the Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy, presented preliminary results from her Phase III study exploring the impact of a combined chem... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Increasing transparency in animal research to sway public opinion, and a reaching a plateau in human mortality
Public opinion on the morality of animal research is on the downswing in the United States. But some researchers think letting the public know more about how animals are used in experiments might turn things around. Online News Editor David Grimm joins Sarah Crespi to talk about these efforts. Sarah also talks Ken Wachter of the University of California, Berkeley about his group’s careful analysis of data from all living Italians born 105 or more years before the study. It turns out the risk of dying does not continue to accelerate with age, but actually plateaus around the age of 105 . What does this mean for attempts...
Source: Science Magazine Podcast - June 28, 2018 Category: Science Authors: Science Source Type: podcasts

Increasing transparency in animal research to sway public opinion, and a reaching a plateau in human mortality
Public opinion on the morality of animal research is on the downswing in the United States. But some researchers think letting the public know more about how animals are used in experiments might turn things around. Online News Editor David Grimm joins Sarah Crespi to talk about these efforts. Sarah also talks Ken Wachter of the University of California, Berkeley about his group ’s careful analysis of data from all living Italians born 105 or more years before the study. It turns out the risk of dying does not continue to accelerate with age, but actually plateaus around the age of 105. What does this mean for attempts t...
Source: Science Magazine Podcast - June 28, 2018 Category: Science Authors: Science Tags: Science Source Type: podcasts

Increasing transparency in animal research to sway public opinion, and a reaching a plateau in human mortality
Public opinion on the morality of animal research is on the downswing in the United States. But some researchers think letting the public know more about how animals are used in experiments might turn things around. Online News Editor David Grimm joins Sarah Crespi to talk about these efforts. Sarah also talks Ken Wachter of the University of California, Berkeley about his group’s careful analysis of data from all living Italians born 105 or more years before the study. It turns out the risk of dying does not continue to accelerate with age, but actually plateaus around the age of 105. What does this mean for attempts...
Source: Science Magazine Podcast - June 28, 2018 Category: Science Authors: Science Magazine Source Type: podcasts

Increasing transparency in animal research to sway public opinion, and a reaching a plateau in human mortality
Public opinion on the morality of animal research is on the downswing in the United States. But some researchers think letting the public know more about how animals are used in experiments might turn things around. Online News Editor David Grimm joins Sarah Crespi to talk about these efforts. Sarah also talks Ken Wachter of the University of California, Berkeley about his group ’s careful analysis of data from all living Italians born 105 or more years before the study. It turns out the risk of dying does not continue to accelerate with age, but actually plateaus around the age of 105. What does this mean for attempts t...
Source: Science Magazine Podcast - June 28, 2018 Category: Science Authors: Science Tags: Science Source Type: podcasts

Unmet needs in amyloidosis
A large contributing factor to outcome in amyloidosis is the stage of diagnosis. Here, Giampaolo Merlini, MD, from the University of Pavia, Paiva, Italy, discusses the need to improve outcomes in pati... Author: VJHemOnc Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Biomarkers of amyloidosis
New insights into amyloid light-chain (AL) amyloidosis have emerged in recent years. Here, Giampaolo Merlini, MD, from the University of Pavia, Paiva, Italy, gives an overview of the mechanisms behind... Author: VJHemOnc Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Integrating molecular variables into prognostic models for patients with MPNs
In this interview, Alessandro Vannucchi, MD, of the University of Florence, Florence, Italy, talks about the new models that doctors can use to determine the prognoses for patients with myeloprolifera... Author: VJHemOnc Added: 11/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 24, 2017 Category: Cancer & Oncology Source Type: podcasts